ArticleScientific reports2024
An attention-based deep learning for acute lymphoblastic leukemia classification.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Incorporating artificial intelligence into morphological diagnosis of acute leukemias: Current landscape, challenges and prospects (Review).Oncology reports · 2026Review
- Improving acute lymphoblastic leukemia diagnosis through CBAM-enhanced VGG19 deep learning.Scientific reports · 2026Article
- Hybrid neutrosophic enhanced MobileNetV2 model for leukemia blood cell classification.Frontiers in artificial intelligence · 2026Article
- Article
- Optimized deep learning ensemble using Fast Osprey algorithm for accurate lymphoblastic leukemia detection.Frontiers in medicine · 2026Article
- Channel-spatial attention modules in convolutional neural networks for image classification.Scientific reports · 2025Article
- Artificial inteligence and datasets for leukemia diagnosis: A scoping review of machine lerning and deep learning approaches.MethodsX · 2025Review
- Neuro-Bridge-X: A Neuro-Symbolic Vision Transformer with Meta-XAI for Interpretable Leukemia Diagnosis from Peripheral Blood Smears.Diagnostics (Basel, Switzerland) · 2025Article
- Deep learning model for early acute lymphoblastic leukemia detection using microscopic images.Scientific reports · 2025Article
- A two stage blood cell detection and classification algorithm based on improved YOLOv7 and EfficientNetv2.Scientific reports · 2025Article
- Hybrid deep layered network model based on multi-scale feature extraction and deep feature optimization for acute lymphoblastic leukemia anomaly detection.PeerJ. Computer science · 2025Article
- CausalFormer-HMC: a hybrid memory-driven transformer with causal reasoning and counterfactual explainability for leukemia diagnosis.Frontiers in cell and developmental biology · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The bone marrow overproduces immature cells in the malignancy known as Acute Lymphoblastic Leukemia (ALL). In the United States, about 6500 occurrences of ALL are diagnosed each year in both children and adults, comprising nearly 25% of pediatric cancer cases. Recently, many computer-assisted diagnosis (CAD) systems have been proposed to aid hematologists in reducing workload, providing correct results, and managing enormous volumes of data. Traditional CAD systems rely on hematologists' expertise, specialized features, and subject knowledge. Utilizing early detection of ALL can aid radiologists and doctors in making medical decisions. In this study, Deep Dilated Residual Convolutional Neural Network (DDRNet) is presented for the classification of blood cell images, focusing on eosinophils, lymphocytes, monocytes, and neutrophils. To tackle challenges like vanishing gradients and enhance feature extraction, the model incorporates Deep Residual Dilated Blocks (DRDB) for faster convergence. Conventional residual blocks are strategically placed between layers to preserve original information and extract general feature maps. Global and Local Feature Enhancement Blocks (GLFEB) balance weak contributions from shallow layers for improved feature normalization. The global feature from the initial convolution layer, when combined with GLFEB-processed features, reinforces classification representations. The Tanh function introduces non-linearity. A Channel and Spatial Attention Block (CSAB) is integrated into the neural network to emphasize or minimize specific feature channels, while fully connected layers transform the data. The use of a sigmoid activation function concentrates on relevant features for multiclass lymphoblastic leukemia classification The model was analyzed with Kaggle dataset (16,249 images) categorized into four classes, with a training and testing ratio of 80:20. Experimental results showed that DRDB, GLFEB and CSAB blocks' feature discrimination ability boosted the DDRNet model F1 score to 0.96 with minimal computational complexity and optimum classification accuracy of 99.86% and 91.98% for training and testing data. The DDRNet model stands out from existing methods due to its high testing accuracy of 91.98%, F1 score of 0.96, minimal computational complexity, and enhanced feature discrimination ability. The strategic combination of these blocks (DRDB, GLFEB, and CSAB) are designed to address specific challenges in the classification process, leading to improved discrimination of features crucial for accurate multi-class blood cell image identification. Their effective integration within the model contributes to the superior performance of DDRNet.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.